Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Cytori Therapeutics (CYTX) Prices Direct Offering at 77c/Unit
-
Cytori Prices Registered Direct Offering Providing for up to $25 million in Equity Financing
-
OpGen (OPGN) Prices IPO at $6/Unit
-
OpGen Announces Pricing of Initial Public Offering
-
Hemisphere Media Group Announces Launch of Secondary Public Offering
-
BioLineRx (BLRX) Bullish Stance Reiterated at Maxim Group After Entering Expansion stage of AML Phase 2 Study
-
Maxim Group Downgrades iGATE (IGTE) to Hold
-
Notable Analyst Rating Changes 4/30: (JBLU) (MDLZ) (PGR) Upgraded; (PAG) (BBVA) (OI) Downgraded
-
Inovio Pharma (INO) Prices 9.5M Common Offering at $8/Share
-
Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Maxim Group Assumes NovaBay Pharmaceuticals (NBY) at Buy
-
StemCells, Inc. Announces Closing of $25 Million Public Offering
-
Maxim Group Starts RestorGenex (RESX) at Buy
-
Maxim Group Upgrades First Internet Bancorp (INBK) to Buy
-
StemCells (STEM) Prices Common, Warrants Offering at $0.70/Unit
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million
-
StemCells (STEM) Falls on Plan to Offer Common Stock and Warrants
-
Maxim Group Starts Radius Health (RDUS) at Buy
-
LookSmart Announces Spin-Off and Definitive Merger Agreement with Pyxis
-
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
Cytori Therapeutics (CYTX) a Step Closer to Clinical Trials, Maxim Group Notes
-
Notable Analyst Rating Changes 4/22: (NOK) (MAS) (PKG) Upgraded; (AGU) (RF) (CMG) Downgraded
-
Pre-Open Stock Movers 04/22: (PKT) (ONVO) (ANGI) Higher; (NRP) (CMG) (URI) Lower (more...)
-
Maxim Group Downgrades Catamaran (CTRX) to Hold
-
After-Hours Stock Movers 04/21: (CAMP) (BRCM) (YUM) Higher; (CMG) (URI) (CREE) Lower (more...)
-
Maxim Group Starts Cardio3 BioSciences SA (CIBSF) at Buy
-
Maxim Group Starts Bluebird Bio (BLUE) at Buy
-
Maxim Positive on Inovio Pharmaceuticals (INO) Following Hepatitis B Trial Initiation
-
Brainstorm Cell Therapeutics (BCLI) Bullish Stance Reiterated at Maxim Group Following ALS Study Data
-
Breathe eCig Corp. Announces Engagement of Investment Banking Firm Maxim Group LLC to Provide Strategic Advisory Services
-
Notable Analyst Rating Changes 4/16: (COH) (INTC) (LOW) Upgraded; (AGCO) (NOK) (TRQ) Downgraded
-
Maxim Group Starts Apple (AAPL) at Hold
-
Notable Analyst Rating Changes 4/15: (GPRO) (DFS) (EVEP) Upgraded; (BLDR) (MPEL) (FMSA) Downgraded
-
Maxim Group Starts Western Digital Corp. (WDC) at Buy
-
Maxim Group Starts Seagate Technology (STX) at Buy
-
Maxim Group Starts Intevac (IVAC) at Hold
-
Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $43.7 Million
-
Maxim Group Starts Information Services (III) at Buy, PT $8
-
Maxim Group Starts Evolving Systems (EVOL) at Buy
-
Notable Analyst Rating Changes 4/9: (IHG) (AUQ) (PTEN) Upgraded; (CTXS) (PHM) (CLF) Downgraded
-
Opexa Therapeutics, Inc. Announces Completion of Rights Offering
-
Edge Therapeutics Raises $72.5 Million Through Successive Series C-1 and C-2 Financings
-
Maxim Group Starts RiceBran Technologies (RIBT) at Buy
-
Maxim Group Starts Garrison Capital (GARS) at Buy
-
Harris & Harris Group Portfolio Company OpGen Files Amended Registration Statement for Proposed Public Offering
-
Approval in China, Orphan Staus from EMA Bode Well for Cytori (CYTX); Maxim Affirms 'Buy' Rating
-
Gladstone Investment Corporation Announces Closing of Over-Allotment Option on Common Stock
-
Gladstone Investment Corporation Announces Closing of Over-Allotment Option on Common Stock

